title: Clinical results with the Acorn cardiac restraint device with and without mitral valve surgery.
abstract: Progressive left ventricular (LV) remodeling is part of the unfavorable natural history in patients with heart failure (HF). The CorCap Cardiac Support Device (CSD) is a mesh device that is implanted around the heart to reduce wall stress and the first therapy specifically designed to address LV remodeling. Early clinical studies have shown that the CSD is safe and associated with improvements in LV structure and function and patient symptoms. The CorCap was studied in the largest prospective randomized multicentered trial of a surgical device ever completed. The study demonstrated both safety and effectiveness of the CorCap in patients with advanced heart failure and remodeled ventricles.
authors.affiliation: Department of Surgery, Hospital of the University of Pennsylvania, Silverstein, PA 19104, USA. michael.acker@uphs.upenn.edu
authors.forename: Michael A
authors.initials: MA
authors.lastname: Acker
mesh_terms: D006348:Cardiac Surgical Procedures / Q000295:instrumentation*; D002311:Cardiomyopathy, Dilated / Q000601:surgery*; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008943:Mitral Valve / Q000601:surgery; D015337:Multicenter Studies as Topic; D019736:Prostheses and Implants; D011474:Prosthesis Design; D013526:Surgical Mesh; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000517:prevention & control*; D020257:Ventricular Remodeling / Q000502:physiology